Article Details

Fresenius Medical Care investing $25M in Humacyte as it goes public in SPAC deal - MassDevice

Retrieved on: 2021-08-30 18:33:45

Tags for this article:

Click the tags to see associated articles and topics

Fresenius Medical Care investing $25M in Humacyte as it goes public in SPAC deal - MassDevice. View article details on hiswai:

Excerpt

“Humacyte's regenerative medicine technology has great potential in many areas of healthcare,” Fresenius global CMO Dr. Franklin W. Maddux said in the ...

Article found on: www.massdevice.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up